[A15-36] Insulin degludec/liraglutide (Addendum to Commission A15-15)
|Commission:||Commission awarded on 2015-09-08 by the Federal Joint Committee (G-BA)|
|Current document:||Addendum to Commission A15-15 Further documents|
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
|Contact address:||to the contact form|
Insulin degludec/liraglutide - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Status: Commission completed
|2015-10-15||Addendum to Commission A15-15||300 kB|
Federal Joint Committee (G-BA)
2015-10-15 A G-BA decision was published.